Crescent vs. Avalon ECMO Cannula: A Deep-Dive Comparison of Dual-Lumen Design, Flow Mechanics, and Clinical Tradeoffs

The Crescent and Avalon dual-lumen ECMO cannulas differ mainly in how they manage drainage and reinfusion within a single vessel: the Avalon relies on a fixed, self-expanding polymethylpentene membrane and preset port geometry, while the Crescent uses a more compact, wire-reinforced design with adjustable positioning and a distinct drainage-to-reinfusion port spacing. That structural difference drives measurable tradeoffs in recirculation, insertion technique, flow ceilings, and imaging confirmation.

Both devices are single-site, dual-lumen cannulas intended for venovenous extracorporeal membrane oxygenation (VV-ECMO) through the internal jugular vein. They replace two separate cannulas with one insertion, reducing vascular access burden. But they are not interchangeable drop-ins. The geometry of each determines where drainage and reinfusion ports sit relative to the right atrium and tricuspid valve, and that position governs how much oxygenated blood recirculates back into the drainage limb instead of reaching the patient.

This explainer goes past the spec sheet. It walks through the flow mechanics that make recirculation inevitable in any dual-lumen cannula, quantifies what clinicians actually measure at the bedside, and separates genuine design differences from marketing language. It also flags where the evidence is thin, because dual-lumen cannula comparisons rest largely on bench studies, single-center series, and registry data rather than randomized trials.

How dual-lumen drainage and reinfusion actually work

A dual-lumen cannula carries two channels inside one tube. Blood drains from the patient through one set of ports, travels to the pump and oxygenator, and returns through a second set of ports. In the Avalon design, drainage ports sit proximally and distally, and the reinfusion port sits in the middle, aimed toward the tricuspid valve. The self-expanding membrane holds the cannula centered in the superior vena cava and right atrium so the reinfusion jet points where it should.

The Crescent cannula uses a similar three-zone architecture but with a different structural approach. Its drainage and reinfusion ports are arranged to reduce direct port-to-port overlap, and the cannula is designed for placement with wire reinforcement that resists kinking at the cavoatrial junction. The reinfusion port orientation and the spacing between drainage and reinfusion zones are the variables that matter most.

Why does port geometry dominate performance? Because recirculation is a spatial problem. Oxygenated blood leaving the reinfusion port can be captured immediately by a nearby drainage port and sent back to the oxygenator. The fraction recaptured is the recirculation fraction, and it directly degrades oxygen delivery efficiency.

The reinfusion jet also creates a local pressure and velocity field. If the jet impinges on the atrial wall or sits too close to a drainage port, recirculation rises. If it sits too far from the tricuspid valve, oxygenated blood may not reach the pulmonary circulation efficiently and could pool. Every dual-lumen design is a compromise between these competing demands.

Plain language: the cannula is a plumbing layout inside the heart, and where the outflow points relative to the inflow determines how much freshly oxygenated blood gets wasted.

What recirculation looks like in measured terms

Recirculation fraction is the share of oxygenated blood that returns to the pump instead of the patient. Clinicians estimate it using blood gas differences across the circuit. A common approach compares oxygen saturation in the drainage limb (pre-oxygenator) with saturation in the reinfusion limb (post-oxygenator) and with arterial saturation.

In practical terms, a recirculation fraction above roughly 20 to 30 percent is where clinicians start troubleshooting position, because effective oxygen delivery falls proportionally. These thresholds are operational rules of thumb, not consensus cutoffs, and different centers use different triggers. The point is that recirculation is continuous, not binary.

Echocardiography guides placement and confirms port position. The reinfusion port should sit near the tricuspid valve, and the drainage ports should straddle the cavoatrial junction without the distal tip migrating into the hepatic veins or the reinfusion jet abutting the atrial wall. Migration of even a few centimeters changes the recirculation fraction.

Flow ceilings differ by cannula size. Dual-lumen cannulas are sized in French units, and larger sizes support higher maximum flows, but the achievable flow also depends on preload, venous return, and drainage resistance. A cannula rated for high flow cannot deliver it if the patient is hypovolemic. This is the professional caveat that bench comparisons often omit: cannula flow ratings are conditional, not guaranteed.

Design differences that change the bedside experience

The Avalon cannula's self-expanding membrane is its signature feature. The membrane deploys in the superior vena cava and right atrium to center the cannula and hold the reinfusion port in position. That centering reduces the chance of the jet impinging on a wall, but it also means the membrane must be positioned correctly during insertion, and repositioning after deployment is more involved.

The Crescent design emphasizes a lower-profile, wire-reinforced body with adjustable depth positioning. That adjustability matters when a patient's anatomy does not match the assumed cavoatrial dimensions, or when the cannula migrates after insertion. Adjustable positioning can reduce recirculation without a full exchange, but it also means correct depth must be confirmed and re-confirmed rather than set once by membrane deployment.

Insertion technique differs as a consequence. The Avalon typically requires a stepwise insertion with confirmation of membrane position. The Crescent allows depth adjustment along the wire-reinforced shaft. Neither is universally easier; operator familiarity and institutional protocol dominate insertion success more than the device label.

Imaging confirmation is essential for both. A cannula that looks correctly placed on chest radiography can still have a reinfusion jet directed at a wall. Echocardiography, not plain film, is the tool that confirms port-to-valve relationships.

Comparison table:

The table shows that the central difference is positional control, not raw flow capacity. Both designs can deliver adequate VV-ECMO flow when correctly sized and positioned. The differentiator is how each handles the inevitable drift between assumed and actual anatomy.

Timeline of placement, confirmation, and troubleshooting

The time course of dual-lumen cannula use follows a predictable arc. Understanding it prevents the common error of treating initial correct placement as permanent.

The counterintuitive detail sits in the surveillance phase. Recirculation can rise gradually as a patient's volume status, heart rate, and cardiac output change, even when the cannula has not moved. A rising recirculation fraction is not proof of migration. It can reflect altered flow dynamics around a correctly positioned cannula. Clinicians who reflexively reposition on every recirculation bump may create new problems.

Where misconceptions and edge cases bite

A persistent misconception is that dual-lumen cannulas eliminate recirculation. They do not. They reduce access-site burden and can lower recirculation compared with poorly positioned two-cannula setups, but recirculation is intrinsic to any design where drainage and reinfusion share a vessel. The question is how much, not whether.

Another misconception is that a higher flow rating means better oxygenation. Flow and oxygen delivery are related but not identical. Recirculation and native cardiac output determine how much of that flow actually reaches the systemic circulation. A cannula running high flow with high recirculation can underperform a lower-flow setup with low recirculation.

Red-flag warnings during use:

A sudden rise in recirculation fraction after stable operation suggests migration or a change in cardiac output, not necessarily device failure. Falling drainage flow with rising negative pressure warns of cannula abutment against a vessel wall or thrombus at the drainage ports. New arrhythmias during or after placement warrant echocardiographic reassessment of port position. Difficulty advancing the cannula over the wire should stop the procedure for reassessment rather than force advancement. Persistent hypoxia despite adequate circuit flow demands a recirculation and positioning review before escalating oxygenator settings.

Edge cases matter. Patients with unusual cavoatrial anatomy, prior cardiac surgery, or a prominent Eustachian valve can distort the assumed port relationships. In these anatomies, the adjustable-depth design may offer an advantage, but it also demands more careful imaging because the assumed landmarks are unreliable. Extremely small patients and those with limited jugular access may not accommodate larger dual-lumen sizes at all, pushing toward alternative configurations.

Practical steps for choosing and managing either cannula

The practical actions below apply to both devices. They focus on what changes outcomes: sizing, confirmation, and surveillance.

Step 1: Size to the patient's measured anatomy, not to a default. Review cavoatrial dimensions on echocardiography or cross-sectional imaging before selecting French size. Undersizing limits flow; oversizing risks vascular injury and malposition.

Step 2: Confirm position with echocardiography at insertion and document the port-to-valve relationship. Plain radiography alone cannot confirm reinfusion jet direction.

Step 3: Establish a baseline recirculation estimate and a surveillance interval. Trending recirculation over time detects drift better than a single measurement.

Step 4: Troubleshoot in order. Check volume status and cardiac output first, then confirm position by imaging, then consider repositioning. Exchange is a last resort because re-cannulation carries its own risk.

Step 5: Reassess after any major change in patient physiology, including large fluid shifts, new arrhythmias, or changes in ventilator strategy. The cannula is fixed; the physiology around it is not.

Thresholds to reconcile: recirculation is often flagged around 20 to 30 percent, but the actionable threshold depends on the patient's oxygen demand and native cardiac function. A patient with high native output may tolerate more recirculation than one dependent on full extracorporeal support. Treat the number as a trigger for assessment, not an automatic instruction.

What the evidence can and cannot tell you

Direct head-to-head randomized comparisons of the Crescent and Avalon cannulas are scarce. Much of what clinicians know comes from bench-flow studies, single-center case series, and registry analyses of dual-lumen versus two-cannula VV-ECMO. Those sources support general conclusions about dual-lumen advantages and recirculation behavior, but they do not establish that one dual-lumen brand outperforms another across populations.

Manufacturer specifications describe sizing ranges and design features, but they do not substitute for independent outcome data. This is the honest limitation: device selection should follow local expertise, available sizes, and the specific anatomy in front of you, informed by the mechanistic reasoning above. The mechanisms are stable and well understood; the comparative outcomes are not.

What can be concluded with confidence is this. Both cannulas solve the same problem through different positional strategies. Recirculation is the central performance variable for both. Imaging confirmation and surveillance matter more than brand. And the patient's changing physiology can degrade a correctly placed cannula without any device fault. Those four points hold regardless of which cannula is on the shelf.

For programs choosing between them, the practical answer is to standardize on one device, train deeply on its insertion and confirmation, and build surveillance protocols around recirculation trending. The marginal design differences are real but smaller than the operational discipline around them. A well-managed Avalon and a well-managed Crescent will both serve patients well. A poorly confirmed cannula of either brand will not.